Hidradenitis Suppurativa
📧 Sign up to get email alerts when something new happens for Hidradenitis Suppurativa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
A Phase 2 proof-of-concept study evaluating subcutaneous amlitelimab in adults with moderate-to-severe hidradenitis suppurativa has been ter…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa [Phase 2]
Phase 2 study evaluating safety and pharmacokinetics of INF904 in adults with chronic spontaneous urticaria or hidradenitis suppurativa was …
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab [Phase 2, Phase 3]
A clinical trial update indicates a long-term study of spesolimab in hidradenitis suppurativa has been terminated (Phase 2/3).
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa [Phase 2]
Sanofi's Phase 2 trial of SAR442970 in adults with hidradenitis suppurativa has completed and results have been posted. The study evaluated …
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients [NA]
A completed clinical trial investigating activation of a cutaneous inflammasome in the skin of patients with hidradenitis suppurativa.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 3]
A Phase 3 study evaluating Povorcitinib (INCB054707) for moderate-to-severe hidradenitis suppurativa has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 2]
A phase 2 trial comparing ATI-450 to placebo in moderate-to-severe hidradenitis suppurativa has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: Periodontal Status and Disease Severity in Hidradenitis Suppurativa Patients
This clinical trial update reports on the periodontal status and disease severity in patients with hidradenitis suppurativa.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Tofacitinib for Immune Skin Conditions in Down Syndrome [Phase 2]
A Phase 2 trial evaluating tofacitinib for immune-mediated skin conditions in individuals with Down syndrome has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Phase 2 study evaluating SAR444656 versus placebo in adults with moderate-to-severe hidradenitis suppurativa was terminated. The document re…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Molecular Evaluation of TAAR1 and JAK/STAT Pathway in Hidradenitis Suppurativa
A completed clinical trial assessing molecular markers related to TAAR1 and the JAK/STAT pathway in hidradenitis suppurativa and related ski…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Hidradenitis Suppurativa Mail Survey
This document reports the completion of a mail survey conducted as part of a Wake Forest University Health Sciences-sponsored clinical trial…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa [Phase 2, Phase 3]
A Phase 2/3 study (Lunsayil 1) evaluating spesolimab for hidradenitis suppurativa has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Hidradenitis Suppurativa Study of Izokibep [Phase 3]
A Phase 3 trial of izokibep for hidradenitis suppurativa was terminated, with results posted in October 2025.
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Hidradenitis Suppurativa Wound Care [Phase 2]
Phase 2 clinical trial evaluating hidradenitis suppurativa wound care has completed and results have been posted. Sponsor: Wake Forest Unive…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of imsidolimab (ANB019) for hidradenitis suppurativa; the study has completed and …
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Mindfulness Training Hidradenitis Suppurativa (HS) [NA]
A University of Miami-sponsored clinical trial assessing mindfulness training for hidradenitis suppurativa (with a focus on quality of life)…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Neutralizing Interferon Type 1 in Hidradenitis Suppurativa [Phase 1]
A Phase 1 clinical trial is evaluating a therapy that neutralizes type 1 interferon in hidradenitis suppurativa. The study status is not yet…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.
This clinical trial update summarizes the impact of untreated depression and anxiety on patients with skin diseases in Jeddah, Saudi Arabia.…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases [NA]
A completed clinical trial conducted by Universitätsklinikum Hamburg-Eppendorf evaluating an online intervention to reduce self-stigma in pe…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial [Phase 2]
This Phase 2 clinical trial update reports long-term Spesolimab treatment in people with hidradenitis suppurativa who completed a prior tria…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
Phase 3 clinical trial is evaluating subcutaneous sonelokimab versus placebo for moderate to severe hidradenitis suppurativa; the study is c…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS). [Phase 2]
A Phase 2 trial evaluating deucravacitinib versus placebo for hidradenitis suppurativa has been terminated; no efficacy or safety results ar…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial evaluating sclerotherapy for treating fistulas and sinus tracts in hidradenitis suppurativa; results have been posted…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
Phase 3 study evaluating the efficacy and safety of bimekizumab in adults with moderate-to-severe hidradenitis suppurativa has completed wit…